Composition and method for altering levels of or sensitivity to adenosine with analogs of dehydroepiandrosterone
US7893044B2 · kind B2 · utility
0Cited by
2References
1Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 20, 2004 |
| Grant date | Feb 22, 2011 |
| Priority date | — |
| Expiry date | Aug 7, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/704
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating adenosine depletion in a subject in need of such treatment is disclosed. The method comprises administering to the subject folinic acid or a pharmaceutically acceptable salt thereof in an amount effective to treat adenosine depletion. A method of treating asthma in a subject in need of such treatment is also disclosed. The method comprises administering to the subject dehydroepiandrosterone, analogs thereof, or pharmaceutically acceptable salts thereof in an amount effective to treat asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.